新冠疫情期间糖尿病足治疗面临的挑战。

Challenges in diabetic foot treatment during pandemic of COVID-19.

机构信息

From the Department of Vascular Surgery (Vukas), from the Department of Neurology (Kadić-Vukas), Cantonal Hospital Zenica, Zenica; from the Department of Vascular Surgery (Dragan Piljic), Cardiovascular Surgery Clinic, and from the Intensive Care (Dilista Piljic), University Clinical Center Tuzla, Clinic of Infective Disease, Tuzla, Bosnia and Herzegovina.

出版信息

Saudi Med J. 2021 Feb;42(2):166-169. doi: 10.15537/smj.2021.2.25687.

DOI:10.15537/smj.2021.2.25687

PMID:33563735

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7989290/

Abstract

OBJECTIVES

To avoid hospital spread of Coronavirus-2019 (COVID-19) and to analyze out of hospital outcomes after amputation.

METHODS

Prospective analysis of data obtained from 60 diabetic patients in 2020 was performed at Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina. Personal protection equipment included double surgical mask, glasses, disposable surgical coats, and surgical masks for patients. Swabs were used to take samples from wounds. We randomly divided patients in 2 groups of 30 patients each. In pre-operative treatment, we used local anesthesia lidocaine hydrochloride 2% (Belupo, Koprivnica, Croatia) in group A and systemic analgesia intravenous tramadol chloride 100 mg intravenous (Krka, Novo Mesto, Slovenia) in group B. Wounds were surgically treated each day and heal spontaneously. Periodical control exams were performed.

RESULTS

Wound healing did not present any statistically significant differences between groups (group A: 69±21.97 and B: 61±22.13 days, t=-1.22; =0.11). No statistically significant differences (<0.05) between groups A and B in wound healing regarding to gender or cigarette use was noted.

CONCLUSION

No significant differences in amputation treatment between the 2 comparative groups were noted. No confirmed COVID-19 infections in medical staff who performed surgical interventions or in treated patients were detected.

摘要

目的

避免医院内 2019 年冠状病毒（COVID-19）的传播，并分析截肢后的院外结果。

方法

在波黑泽尼察州立医院对 2020 年的 60 名糖尿病患者进行了前瞻性数据分析。个人防护设备包括双手术口罩、眼镜、一次性手术服和患者的手术口罩。使用拭子从伤口取样。我们将患者随机分为两组，每组 30 名。在术前治疗中，A 组使用局部麻醉盐酸利多卡因 2%（克罗地亚科普里夫尼察的 Belupo），B 组使用全身镇痛盐酸曲马多 100mg 静脉注射（斯洛文尼亚新梅斯托的 Krka）。每天对伤口进行手术治疗并自行愈合。定期进行控制检查。